18 min listen
Anglerfish, Gila Monsters, and the Origin of Weight Loss Drugs
Anglerfish, Gila Monsters, and the Origin of Weight Loss Drugs
ratings:
Length:
20 minutes
Released:
Jul 30, 2023
Format:
Podcast episode
Description
Weight loss drug sales are estimated to hit $44 billion by 2030. Many of these treatments can thank previously obscure research on a carnivorous deep sea fish for their development. Rolfe Winkler is a reporter for the Wall Street Journal covering digital health. Ricky Mulvey caught up with Winkler to discuss: - The origins and science behind weight loss drugs. - The challenge of selling lizard venom research to pharmaceutical companies. - What decades-old research on anglerfish reveals about modern side effects for Ozempic. - And why it’s “not too hard” to keep dozens of Gila Monsters in your basement. “Monster Diet Drugs Like Ozempic Started With Actual Monsters”: https://www.wsj.com/articles/ozempic-mounjaro-gila-monster-anglerfish-8c9c1ff2 Companies mentioned: NVO, LLY Host: Ricky Mulvey Guest: Rolfe Winkler Engineers: Tim Sparks, Heather Horton
Released:
Jul 30, 2023
Format:
Podcast episode
Titles in the series (100)
Motley Fool Money: 04.03.2009: Unemployment rises to its highest level since 1983. G20 leaders agree to toughen up and pay up. President Obama shows some tough love to US automakers. And rumors swirl that Google may be sweet on Twitter. So what does it mean for investors?... by Motley Fool Money